本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Janux Therapeutics, Inc.

28.55
-0.7300-2.49%
成交量:58.87萬
成交額:1,718.99萬
市值:17.17億
市盈率:-16.99
高:29.94
開:28.92
低:28.34
收:29.28
52周最高:71.71
52周最低:21.73
股本:6,014.78萬
流通股本:4,496.69萬
量比:0.76
換手率:1.31%
股息:- -
股息率:- -
每股收益(TTM):-1.6802
每股收益(LYR):-1.2836
淨資產收益率:-12.48%
總資產收益率:-10.49%
市淨率:1.76
市盈率(LYR):-22.24

資料載入中...

2024/12/05

重要事件披露

Form 8-K - Current report
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/05

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/25

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities